Mobilization of giant piggyBac transposons in the mouse genome

The development of technologies that allow the stable delivery of large genomic DNA fragments in mammalian systems is important for genetic studies as well as for applications in gene therapy. DNA transposons have emerged as flexible and efficient molecular vehicles to mediate stable cargo transfer. However, the ability to carry DNA fragments >10 kb is limited in most DNA transposons. Here, we show that the DNA transposon piggyBac can mobilize 100-kb DNA fragments in mouse embryonic stem (ES) cells, making it the only known transposon with such a large cargo capacity. The integrity of the cargo is maintained during transposition, the copy number can be controlled and the inserted giant transposons express the genomic cargo. Furthermore, these 100-kb transposons can also be excised from the genome without leaving a footprint. The development of piggyBac as a large cargo vector will facilitate a wider range of genetic and genomic applications.

[1]  A. Bradley,et al.  A hyperactive piggyBac transposase for mammalian applications , 2011, Proceedings of the National Academy of Sciences.

[2]  K. Kawakami,et al.  Transposon-mediated BAC transgenesis in zebrafish and mice , 2009, BMC Genomics.

[3]  A. Bradley,et al.  Chromosomal mobilization and reintegration of Sleeping Beauty and PiggyBac transposons , 2009, Genesis.

[4]  J. Boeke,et al.  Transposon-mediated genome manipulation in vertebrates , 2009, Nature Methods.

[5]  Wei Wang,et al.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.

[6]  A. Bradley,et al.  Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon , 2009, Nature Methods.

[7]  K. Woltjen,et al.  Virus free induction of pluripotency and subsequent excision of reprogramming factors , 2009, Nature.

[8]  David G. Melvin,et al.  Chromosomal transposition of PiggyBac in mouse embryonic stem cells , 2008, Proceedings of the National Academy of Sciences.

[9]  K. Steel,et al.  Mosaic Complementation Demonstrates a Regulatory Role for Myosin VIIa in Actin Dynamics of Stereocilia , 2007, Molecular and Cellular Biology.

[10]  Claudia Seisenberger,et al.  Splinkerette PCR for more efficient characterization of gene trap events , 2007, Nature Genetics.

[11]  A. Bradley,et al.  Generation of an inducible and optimized piggyBac transposon system , 2007, Nucleic acids research.

[12]  David G. Melvin,et al.  A recombineering based approach for high-throughput conditional knockout targeting vector construction , 2007, Nucleic acids research.

[13]  J. Hughes,et al.  Manipulating the Mouse Genome to Engineer Precise Functional Syntenic Replacements with Human Sequence , 2007, Cell.

[14]  R. Wade-Martins,et al.  Delivery of large genomic DNA inserts >100 kb using HSV-1 amplicons. , 2006, Current gene therapy.

[15]  Min Han,et al.  Efficient Transposition of the piggyBac (PB) Transposon in Mammalian Cells and Mice , 2005, Cell.

[16]  Z. Izsvák,et al.  Development of hyperactive sleeping beauty transposon vectors by mutational analysis. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  K. Kawakami,et al.  Transposition of the Tol2 element, an Ac-like element from the Japanese medaka fish Oryzias latipes, in mouse embryonic stem cells. , 2004, Genetics.

[18]  A. F. Stewart,et al.  High-throughput engineering of the mouse genome coupled with high-resolution expression analysis , 2003, Nature Biotechnology.

[19]  L. Montoliu,et al.  Size Matters: Use of YACs, BACs and PACs in Transgenic Animals , 2001, Transgenic Research.

[20]  D. Court,et al.  A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. , 2001, Genomics.

[21]  Robert E. White,et al.  Stable correction of a genetic deficiency in human cells by an episome carrying a 115 kb genomic transgene , 2000, Nature Biotechnology.

[22]  A. Bradley,et al.  A new positive/negative selectable marker, puΔtk, for use in embryonic stem cells , 2000 .

[23]  R. Plasterk,et al.  Molecular Reconstruction of Sleeping Beauty , a Tc1-like Transposon from Fish, and Its Transposition in Human Cells , 1997, Cell.

[24]  A. Bradley,et al.  Chromosome engineering in mice , 1995, Nature.

[25]  H. G. Wang,et al.  Transposon mutagenesis of baculoviruses: analysis of Trichoplusia ni transposon IFP2 insertions within the FP-locus of nuclear polyhedrosis viruses. , 1989, Virology.

[26]  A. Bradley,et al.  A potential animal model for Lesch–Nyhan syndrome through introduction of HPRT mutations into mice , 1987, Nature.

[27]  A. Bradley,et al.  Genome-wide forward genetic screens in mouse ES cells. , 2010, Methods in enzymology.

[28]  A. Bradley,et al.  A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells. , 2000, Genesis.

[29]  T. Yagi,et al.  Efficient production of Cre-mediated site-directed recombinants through the utilization of the puromycin resistance gene, pac: a transient gene-integration marker for ES cells. , 1998, Nucleic acids research.

[30]  T. Doetschman,et al.  Gene targeting in embryonic stem cells. , 1991, Biotechnology.